Pituitary tumours, though almost always benign, are now included with other central nervous system tumours in cancer services. It therefore seems appropriate to adapt this oncology tool for use with pituitary patients.
• Research has shown that high levels of patient distress may not be identified during consultations with healthcare professionals (HCPs), resulting in significant patient dissatisfaction with care and additional use of primary and secondary care services [1] .
• Routinely used in oncology services, the a distress thermometer is a structured way for a nurse or other HCP to discuss with a patient some of the concerns (practical, emotional, physical and psychological) that they may be experiencing.
• A distress thermometer offers patients a list of common difficulties. After the patient has completed the distress thermometer, it can then be used collaboratively by the patient & HCP to discuss options for dealing with the difficulties causing the most distress for the patient.
• 901 completed surveys were returned.
• Respondents' age ranged from 18 to 90 years (mean age 59.13±14.25)
• 60% of participants were female
• Hypopituitarism was the most commonly reported diagnosis (43%).
• Multivariate regression modelling was used to determine the symptom clusters associated with the various diagnoses reported by respondents.
• The final analysis generated a 39-item problem-list for the PDT, comprising 32 symptoms, 3 practical problems, and 4 emotional concerns.
• Only one third of Oncology DT items (n=13) appear on the PDT.
• In terms of symptom clusters per pituitary condition, Cushings disease recorded the largest symptom list (n=24 symptoms), while both prolactinoma and nonfunctioning tumour had the smallest lists (n=4 items).
Many studies using disease-specific questionnaires have demonstrated distress in patients with pituitary disease, which may not be disclosed or discussed during regular consultations [2] [3] [4] [5] [6] . The PDT offers a potential solution, as well as illustrating the need for the development of disease-specific distress thermometers and greater knowledge about specific symptom clusters as reported by patients.
• Working with the Pituitary Foundation, a Wellbeing Survey was generated, comprising 36 pituitary-specific items, plus all 40 items from the Oncology Distress Thermometer (ODT).
• The Survey was posted to all Pituitary Foundation members (n=2,500), enclosed with Pit Life (the magazine of the Pituitary Foundation). 
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Figure 1: Front page of the Pituitary Distress Thermometer
